Revive Therapeutics Ltd (FRA:31R) Stock News, Headlines & Updates
Revive Therapeutics Ltd Stock News from GuruFocus
- 1
Jul 08, 2025
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
Marketwired • 5:00pm
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study | RVVTF Stock News
GuruFocus News • 4:30pm
Jun 26, 2025
Revive Therapeutics (RVVTF) Advances Bucillamine Study for Nerve Agent Exposure | RVVTF Stock News
GuruFocus News • 6:48am
Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity | RVVTF Stock News
GuruFocus News • 6:20am
Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity
Marketwired • 6:00am
Jun 04, 2025
Revive Therapeutics Advances with Next-Generation Bucillamine Development | RVVTF Stock News
GuruFocus News • 6:15am
Revive Therapeutics Advances with Next-Generation Bucillamine Development
Marketwired • 6:00am
May 12, 2025
- 1
Show
Entries
Headlines
Total 0- 1
No recent news